Analysis of the Incidence and Prevalence of Rheumatic Diseases in Khabarovsk Krai (2015–2024)
Abstract Relevance. Rheumatic diseases are a leading cause of chronic pain, disability, and reduced quality of life and life expectancy among the adult population. Studying their incidence and prevalence at the regional level is essential for evidence-based planning of rheumatological care. Objective. To analyze the trends in the incidence and prevalence of rheumatic diseases among the adult population of Khabarovsk Krai from 2015 to 2024 and, based on the findings, to outline directions for improving rheumatological care in the region. Materials and Methods. A retrospective analysis was conducted using official data from Federal Statistical Observation Form No. 12, provided by the Medical Information and Analytical Center of the Ministry of Health of Khabarovsk Krai. We assessed the incidence (newly diagnosed cases) and prevalence per 100,000 population among adults (≥18 years) for the group of diseases classified under Class XIII (diseases of the musculoskeletal system and connective tissue), as well as for specific subgroups – arthropathies, systemic connective tissue disorders, and spondylopathies – with a focus on reactive arthritis, rheumatoid arthritis, osteoarthritis, systemic lupus erythematosus, and ankylosing spondylitis. Results. Diseases of the musculoskeletal system accounted for 7.3 % to 9.6 % of total morbidity. The incidence of arthropathies rose from 330.6 to 409.3 per 100,000, with lows observed in 2016 and 2021; their prevalence decreased from 3106.5 to 2900.1 per 100,000. The incidence of rheumatoid arthritis increased from 31.7 to 36.0 per 100,000, and prevalence rose from 253.8 to 302.1 per 100,000, driven by a peak in 2023–2024. Reactive arthritis showed a sharp decline: incidence fell from 23.7 to 1.4 per 100,000, and prevalence dropped from 41.9 to 33.2 per 100,000. The incidence of osteoarthritis ranged from 198.8 (in 2021) to 335.9 (in 2019) per 100,000 population, while its prevalence decreased from 2593.1 to 2161.7 per 100,000. The incidence of systemic lupus erythematosus declined from 1.2 to 0.7 per 100,000, whereas prevalence rose from 5.4 to 6.8 per 100.000. Both the incidence and prevalence of ankylosing spondylitis increased – from 5.2 to 6.2 and from 41.8 to 56.9 per 100.000, respectively. The most pronounced decline in incidence and prevalence rates for a number of conditions occurred between 2020–2022. Conclusion. The findings underscore the need to establish regional registries for rheumatic diseases and to enhance the training of primary care physicians in the early diagnosis of systemic diseases; suc
Authors
- A. Yu. Subbotin
- S.G. Maltsev
- I.A. Cherentsova
Institutions
- Khabarovsk State University of Economics and Law (RU)
- Khabarovsk Scientific Research Institute of Epidemiology and Microbiology (RU)
- Far Eastern Law Institute of Ministry of Internal Affairs of Russia (RU)
Publication Details
- Journal
- Public health of the Far East Peer-reviewed scientific and practical journal
- Published
- 2026-11-17
- DOI
- https://doi.org/10.33454/1728-1261-2026-4-4-10
- Primary Topic
- Musculoskeletal pain and rehabilitation
- Type
- article
- Field-Weighted Citation Impact
- 0.00